Abnormal upregulation of CCL2 results in sustained and exacerbated cell recruitment and uncontrolled inflammation [38], as seen in rheumatoid arthritis, atherosclerosis, diabetes and COVID-19, among others [39,40,41,42,43,44]. Here, CCL2 is linked to rheumatoid arthritis.